Home » Trials » SLCTR/2026/027


Impact assessment: Provision of Fortified Rice to School children aged 8 - 9 years in Sri Lanka

-

SLCTR Registration Number

SLCTR/2026/027


Date of Registration

06 Oct 2026

The date of last modification

Oct 06, 2026



Application Summary


Scientific Title of Trial

Impact assessment: Provision of Fortified Rice to School children aged 8 - 9 years in Sri Lanka


Public Title of Trial

The effect of fortified rice on iron status and anthropometric outcomes compared to non-fortified rice in schoolchildren aged 8–9 years in Sri Lanka: a randomized controlled trial.


Disease or Health Condition(s) Studied

Iron deficiency anaemia


Scientific Acronym

None


Public Acronym

None


Brief title

None


Universal Trial Number

U1111-1338-9568


Any other number(s) assigned to the trial and issuing authority

MRI-ERC approval No. 26/2024


Trial Details


What is the research question being addressed?

Does provision of fortified rice through the school meal programme improve iron status and anthropometric outcomes among schoolchildren aged 8–9 years in Sri Lanka compared with non-fortified rice?


Type of study

Interventional


Study design

Allocation

Randomized controlled trial


Masking

Double blinded : Participants, Outcome assessors


Control

Active


Assignment

Parallel


Purpose

Screening


Study Phase

Not Applicable


Intervention(s) planned

Setting and allocation: This is a two-arm, parallel, cluster randomised trial in Type 2 and Type 3 government schools in Hambantota District, Sri Lanka. Schools will be allocated 1:1 to the intervention or control arm using stratified block randomisation. One classroom will be selected from each school, with 15 children enrolled per classroom. The planned sample is 12 schools and 180 children per arm. Masking will not be used.

Intervention arm — fortified rice: Each participating child will receive 75 g of cooked rice on every school day through the school meal programme for six months. The rice will be prepared from raw rice fortified with 7 mg elemental iron (as micronised ferric pyrophosphate) and 65 µg folic acid per 100 g of raw rice.

Control arm — non-fortified rice: Each participating child will receive 75 g of cooked, non-fortified rice on every school day through the same school meal programme for six months. This is an active comparator, as children in both arms receive a school meal; the comparison concerns rice fortification.


Inclusion criteria

  1. Male and female children aged 8–9 years in Grades 3 or 4.
  2. Attending a Type 2 or Type 3 government school in Hambantota District that was newly incorporated into the school meal programme in 2024.
  3. Have not previously received fortified rice.
  4. Have received their last weekly iron and folic acid supplement within the preceding six months, as currently stated in the application.

Exclusion criteria

  1. Consumption of school meal
  2. Receiving therapeutic iron treatment.
  3. Moderate anaemia at screening (haemoglobin 8–10.9 g/dL) or severe anaemia (haemoglobin <8 g/dL).
  4. Known major haemoglobinopathy, such as thalassaemia or sickle cell disease.
  5. Diagnosed chronic disease, including chronic liver or renal disease, asthma, congenital heart disease or epilepsy.
  6. Known drug or food allergy.


Primary outcome(s)

1.

Change in haemoglobin level: Haemoglobin concentration measured from venous blood using a three-part haematology analyser (Full Blood Count with Hb)

[

Baseline, 3 months, and 6 months

]
2.

Change in serum ferritin level Serum ferritin concentration measured from venous blood using a fully automated immunoassay analyser

[

Baseline, 3 months, and 6 months

]

Secondary outcome(s)

1.

Change in prevalence of anaemia: Proportion of participants meeting anaemia criteria based on haemoglobin assessment

[

Baseline, 3 months, and 6 months

]
2.

Change in prevalence of iron deficiency: proportion of participants meeting iron deficiency criteria based on serum ferritin with CRP correction

[

Baseline, 3 months, and 6 months

]
3.

Change in prevalence of iron deficiency anaemia: Iron deficiency anaemia defined as presence of both anaemia and iron deficiency; ferritin <12 µg/L if CRP <6 mg/L or ferritin <15 µg/L if CRP >5 mg/L

[

Baseline, 3 months, and 6 months

]
4.

Change in height: Height measured using a stadiometer

[

Baseline, 3 months, and 6 months

]
5.

Change in weight: Weight measured using a Seca weighing scale

[

Baseline, 3 months, and 6 months

]
6.

Change in mid-upper arm circumference (MUAC): MUAC measured using a non-stretchable MUAC tape

[

Baseline, 3 months, and 6 months

]

Target number/sample size

360 participants total (180 per arm, 12 clusters (classrooms) per arm, 15 children per classroom


Countries of recruitment

Sri Lanka


Anticipated start date

2026-10-08


Anticipated end date

2027-10-08


Date of first enrollment


Date of study completion


Recruitment status

Pending


Funding source

Gates foundation


Regulatory approvals

Ministry of Health



State of Ethics Review Approval


Status

Approved


Date of Approval

2024-12-20


Approval number

26/2024


Details of Ethics Review Committee

Name: Medical Research Institute - Ethics Review Committee
Institutional Address:Medical Research Institute Colombo 8
Telephone:0112 693 532
Email: ethics.mri@gmail.com

Contact & Sponsor Information


Contact person for Scientific Queries/Principal Investigator

Dr. Thimathi Wickramasekara
Head- Department of Nutrition
Department of Nutrition, Medical Research Institute, P.O. Box: No. 527, Dr. Danister De Silva Mawatha (Baseline road), Colombo 08
0112 693532



Contact Person for Public Queries

Dr. Thimathi Wickramasekara
Head- Department of Nutrition
Department of Nutrition, Medical Research Institute, P.O. Box: No. 527, Dr. Danister De Silva Mawatha (Baseline road), Colombo 08
0112 693532




Primary study sponsor/organization

Medical Research Institute
Director, MRI
PO Box 527, Dr. Danister De Silva Mawatha, Colombo 8, Western, Colombo, 00800, Sri Lanka
0112 693 532

director@mri.gov.lk

Secondary study sponsor (If any)

Gates Foundation
Lead - Nutrition
P. O. Box 23350 Seattle, Washington 98102 USA


ruchika.chughsachdeva@gatesfoundation.org

Trial Completion details


Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?

No


IPD sharing plan description


Study protocol available

Yes


Protocol version and date



Results summary available

No


Date of posting results


Date of study completion


Final sample size


Date of first publication


Link to results


Brief summary of results